Latest Cytori Stories
Cytori Therapeutics (NASDAQ: CYTX) announced today the publication of RESTORE-2 trial results in the peer-reviewed European Journal of Surgical Oncology.
Cytori (NASDAQ: CYTX) received its first order from Green Hospital Supply for a StemSource(R) Cell Bank, which will be installed in one of the leading public universities in Japan.
Two surgeons today reported their experience in performing cell-enhanced reconstruction on 52 patients from Europe and Israel.
Cytori (NASDAQ: CYTX) will host its second quarter results conference call at 10:30 am Eastern Daylight Time, not 10:00 am. About Cytori Cytori's (NASDAQ: CYTX) goal is to be the global leader in regenerative medicine.
Cytori (NASDAQ:CYTX) sold its first European Union StemSource(R) Cell Bank as part of an agreement with Biohellenika (www.biohellenika.gr).
- Any of various tropical Old World birds of the family Indicatoridae, some species of which lead people or animals to the nests of wild honeybees. The birds eat the wax and larvae that remain after the nest has been destroyed for its honey.